Biofilms Treatment Market Scope And Analysis

Report Code : TIPRE00015873
Category : Life Sciences

No. of Pages : 150

Buy Now

Biofilms Treatment Market Scope, Analysis, and Trends by 2031

Buy Now

Biofilms Treatment Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 1.82 billion
Market Size by 2031	US$ 3.88 Billion
Global CAGR (2023 - 2031)	8.0%
Historical Data	2021-2023
Forecast period	2024-2031
Segments Covered	By Product Debridement Equipment Gauzes and Dressings Grafts and Matrices By Wound Type Traumatic and Surgical Wounds Diabetic Foot Ulcers Pressure Ulcers Venous Leg Ulcers By End User Hospitals Home Care Settings
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Mimedx Group Inc Convatec Group Plc Coloplast A S Mlnlycke Healthcare AB Organogenesis Holdings Inc Integra Lifesciences Holdings Corporation B Braun Melsungen AG Paul Hartmann AG Medline Industries Inc Smith Nephew Plc

Biofilms Treatment Market News and Recent Developments

The biofilms treatment market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for biofilms treatment:

The Cystic Fibrosis Foundation invested up to US$5 million in Clarametyx Biosciences to develop CMTX-101, a drug that could help address difficult-to-treat bacteria such as chronic Pseudomonas aeruginosa, a major cause of lung infections in people with cystic fibrosis. (Cystic Fibrosis Foundation, News, 2024)
Trellis Bioscience Inc., a pioneering biotechnology company focused on the discovery and development of native human monoclonal antibodies, announced that its lead antibody candidate, TRL1068, had been granted Fast Track and QIDP designations by the US Food and Drug Administration (FDA). (Source: Trellis Bioscience, Inc., News, 2024)
Asep Medical Holdings Inc. announced the use of artificial intelligence (AI) that enabled the development of new and improved treatments for common biofilm infections and rapid sepsis diagnostics. (Source: ASEP Medical Holdings Inc., News, 2024)
Medline and OMNIA Partners announced new purchasing partnership. The agreement offered medical-surgical product portfolio cost savings to public sector agencies. Eligible public agencies included state, county and local government, primary and higher education systems and public safety services will be able to tap into Medline’s full portfolio of more than 300,000 medical supplies. (Medline Industries, LP, Press Release, 2022)

Biofilms Treatment Market Report Coverage and Deliverables

The “Biofilms TreatmentMarket Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles